Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-020199
Filing Date
2012-04-04
Accepted
2012-04-04 17:59:11
Documents
3
Period of Report
2012-04-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v308553_3.html 3  
1 OWNERSHIP DOCUMENT v308553_3.xml 3 1678
2 EXHIBIT 24.1 v308553_ex24-1.htm EX-24.1 343
3 GRAPHIC v308553_ex24x1x1x1.jpg GRAPHIC 102529
  Complete submission text file 0001144204-12-020199.txt   145155
Mailing Address 420 LEXINGTON AVENUE SUITE 450 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 450 NEW YORK NY 10170 212-584-4171
NeoStem, Inc. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170
Business Address
Sackner-Bernstein Jonathan (Reporting) CIK: 0001546561 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33650 | Film No.: 12743148